A randomised trial of sequential aromatase inhibitors (AI) in postmenopausal women with locally advanced or metastatic breast cancer
Not Applicable
Completed
- Conditions
- Breast cancerCancer
- Registration Number
- ISRCTN99515843
- Lead Sponsor
- International Collaborative Cancer Group (ICGG) (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 0
Inclusion Criteria
1. Patients with positive estrogen receptor (ER) and/or progesterone receptor (PgR) status
2. Postmenopausal
3. Measurable or accessible locally advanced, unresectable or locoregionally recurrent or metastatic breast carcinoma with documented disease progression
4. At least one bidimensionally measurable lesion should be available for assessment
5. Patients would have failed to respond to previous first line treatment with anti-oestrogens
Exclusion Criteria
Not provided at time of registration
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method